Singapore Paincare Holdings (SGX:FRQ) ROCE % : 12.61% (As of Dec. 2023)

View and export this data going back to 2020. Start your Free Trial

What is Singapore Paincare Holdings ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Singapore Paincare Holdings's annualized ROCE % for the quarter that ended in Dec. 2023 was 12.61%.

Singapore Paincare Holdings ROCE % Historical Data

The historical data trend for Singapore Paincare Holdings's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Singapore Paincare Holdings ROCE % Chart

Singapore Paincare Holdings Annual Data

Trend

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

ROCE %

Get a 7-Day Free Trial

123.99

41.61

14.24

17.73

4.88

Singapore Paincare Holdings Semi-Annual Data
	Jun17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
ROCE %	Get a 7-Day Free Trial								19.47	16.76	11.47	-2.12	12.61

Singapore Paincare Holdings ROCE % Calculation

Singapore Paincare Holdings's annualized ROCE % for the fiscal year that ended in Jun. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Jun. 2023 )		(A: Jun. 2022 )		(A: Jun. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Jun. 2023 )		(A: Jun. 2022 )		(A: Jun. 2023 )
	=	1.469	/	( ( (38.728 - 6.194)	+	(40.205 - 12.52) )	/ 2 )
	=	1.469	/	( (32.534	+	27.685)	/ 2 )
	=	1.469	/	30.1095
	=	4.88 %

Singapore Paincare Holdings's ROCE % of for the quarter that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Dec. 2023 )		(Q: Jun. 2023 )		(Q: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Dec. 2023 )		(Q: Jun. 2023 )		(Q: Dec. 2023 )
	=	3.67	/	( ( (40.205 - 12.52)	+	(40.056 - 9.519) )	/ 2 )
	=	3.67	/	( ( 27.685	+	30.537 )	/ 2 )
	=	3.67	/	29.111
	=	12.61 %

(1) Note: The EBIT data used here is two times the semi-annual (Dec. 2023) EBIT data.

Singapore Paincare Holdings (SGX:FRQ) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Singapore Paincare Holdings ROCE % Related Terms

Thank you for viewing the detailed overview of Singapore Paincare Holdings's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Singapore Paincare Holdings (SGX:FRQ) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Singapore Paincare Holdings Ltd (SGX:FRQ) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

N/A

Address

601 Macpherson Road, No. 06-20/21 Grantral Mall, Singapore, SGP, 368242

Website

https://www.sgpaincareholdings.com

Singapore Paincare Holdings Ltd is a medical services group engaged in pain care services, and primary care and other services. It offers Pain care services focused on the treatment of patients suffering from chronic pain. Its pain care services include, among others, minimally invasive procedures, cancer pain treatment, specialised injections, pharmacotherapy, and cognitive behavioural therapy. Its Primary care and other services provide general medical consultations, management of chronic and acute conditions, and dermatology services. Through its associated company, it also provides health screening services. The company derives its revenue from Singapore.

Singapore Paincare Holdings (SGX:FRQ) Headlines

No Headlines